한국어
English
日本語
中文(简体)Agripal S1 Pre-filled Syringe (Influenza Surface Antigen Vaccine)
15μg
Prescription medication · Combination
Seqirus Korea Co., Ltd.
Inactivated influenza virus antigen type A is a vaccine component for the prevention of influenza A infection.
MFDS ingredient code M266294
This component is an antigen that is purified by inactivating the influenza A virus. It is used in vaccines to help the immune system recognize and respond to the virus. It is primarily used for the purpose of preventing influenza infection.
When this antigen is injected into the body, immune cells recognize it and produce antibodies. These formed antibodies respond quickly when the actual influenza virus invades, preventing infection. Thus, it plays a role in building immunity against the influenza A virus.
Approved uses differ by product. Check each product's information for its actual use.
This component is made from inactivated viruses rather than live viruses, resulting in a high level of safety. Unlike split vaccines, it includes the whole virus antigen to induce an immune response. It is a vaccine tailored to seasonal epidemic strains using specific virus strains.
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Even with the same ingredient, dosage and approved uses can differ by strength, dosage form and combined ingredients. Check each product's information before taking it.
Ingredients used together with this ingredient in combination products.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.